Clinical trial Recruiting at 2 sites Phase2; Phase3 Interventional Ages 18 to 75

Noninvasive spinal cord stimulation to improve arm function

Official title: Transcutaneous Spinal Cord Stimulation to Facilitate Recovery of Upper Extremity Function in Individuals With Stroke or Spinal Cord Injury - A Pilot Study

Run by University of Alberta · NCT06596369 · Data updated 2026-11-12

This study is testing whether a new type of electrical stimulation can help improve arm function in people with spinal cord injuries or strokes when combined with therapy.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of Alberta
Academic / other
Locations2 sites (Edmonton, Alberta and 1 other locations)
StatusRecruiting
StartedJune 15, 2024
Main results expectedSeptember 14, 2029
Study endsDecember 30, 2029
Registry record updatedApril 13, 2026
Trial IDNCT06596369 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18 to 75 with cervical spinal cord injuries or upper extremity motor dysfunction post-stroke.

Probably not a fit

Patients with acute spinal cord injuries or those with severe motor dysfunction who cannot participate in rehabilitation activities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of transcutaneous electrical stimulation (tcES) on upper extremity function in individuals with spinal cord injuries and stroke. It aims to explore how different stimulation parameters, such as electrode placement and frequency, influence neural excitability and motor function. Participants will undergo a combination of tcES and activity-based therapy, with assessments to evaluate improvements in upper extremity function. The study employs a comprehensive set of neurophysiological techniques to link stimulation effects with functional outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly enhance upper extremity function in patients with spinal cord injuries and stroke.

How similar studies have gone: Previous studies have shown promise with invasive spinal cord stimulation, but the noninvasive approach being tested here is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

SCI cohort:

* individuals aged 18 to 75 years of age who have suffered a spinal cord injury
* cervical level injury (C3 to C8)
* at least 1-year post-injury
* for individuals taking medications for spasmolysis or muscle relaxation (e.g. oral baclofen, tizanidine, dantrolene, vigabatrin, gabapentin, or benzodiazepine), dose and regimen must be stable for at least 4 weeks prior to screening

Stroke cohort:

* individuals aged 18-75 years of age who have suffered any type of stroke resulting in upper extremity motor dysfunction with partially preserved motor function
* ≥ 6 months post-stroke
* At least 4 months since last BoNT injection for treatment of spasticity or any other condition or ≤ 2 months after study completion
* for individuals taking medications for spasmolysis or muscle relaxation (e.g. oral baclofen, tizanidine, dantrolene, vigabatrin, gabapentin, or benzodiazepine), dose and regimen must be stable for at least 4 weeks prior to screening

Exclusion Criteria:

* pregnant women
* aphasia or dysphasia
* spasticity grade Modified Ashworth Scale ≥ 3

Transcranial magnetic stimulation-specific exclusion criteria (both cohorts)

* participants with active or inactive implants including cardiac pacemakers, implantable defibrillators, ocular implants, deep brain stimulators, vagus nerve stimulator, and implanted medication pumps
* participants with conductive, ferromagnetic or other magnetic-sensitive metals implanted in their head
* participants with a history of seizures or epilepsy
* participants taking any medication which may reduce seizure threshold

Where it's running

  • Glenrose Rehabilitation Hospital
    Edmonton, Alberta, Canada
    Recruiting
  • University of Alberta
    Edmonton, Alberta, Canada
    Recruiting

Study contacts

  • Principal investigator: Jessica D'Amico, PhD — University of Alberta
  • Study coordinator: Jessica D'Amico, PhD
  • Email: damico1@ualberta.ca
  • Phone: 7807357917

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Robot-assisted training for arm and leg movement after stroke or injury

    This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.

    Recruiting Bangladesh Medical University · Dhaka · NCT07749625

  • ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab

    This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.

    Recruiting Bangladesh Medical University · Dhaka, Dhaka Division · NCT07705906

  • Deep phenotyping to explore recovery in young adults after stroke

    This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

    Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

  • Stem cell therapy for chronic stroke recovery

    This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

    Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

  • Smart rehabilitation for stroke and spinal cord injury patients

    This study tests whether a smart rehabilitation system using a robot can help stroke and spinal cord injury patients improve their movement and daily activities better than a regular home program.

    Recruiting at 2 sites National Cheng-Kung University Hospital · Tainan and 1 other locations · NCT06215625

  • Using Continuous Passive Motion to Prevent Heterotopic Ossification

    This study is trying out a special movement therapy to see if it helps prevent bone growth problems in ICU patients with brain or spinal injuries.

    Recruiting University of Ioannina · Ioannina, Epirus · NCT05906056

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.